A new formulation of Gilead’s HIV prevention drug, lenacapavir, has shown promise in providing yearlong protection with just one injection.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
A new formulation of Gilead’s HIV prevention drug, lenacapavir, has shown promise in providing yearlong protection with just one injection.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis